Characterization of the breast cancer cell lines using fluorescence spectroscopy
Niloofar Taheri
1
(
Department of Atomic and Molecular Physics, Faculty of Physics, Alzahra University, Tehran, Iran
)
Mahsa Ghezelbash
2
(
Department of Electronics, Faculty of Electrical and Computer Engineering, Malek Ashtar University of Technology
)
Reihaneh Ramezani
3
(
Department of Family Therapy, Women Research Center, Alzahra University, Tehran, Iran
)
Batool Sajad
4
(
Department of Atomic and Molecular Physics, Faculty of Physics, Alzahra University, Tehran, Iran
)
کلید واژه: Fluorescence, Spectroscopy, Breast Cancer, Diagnosis, Fluorophores,
چکیده مقاله :
Breast cancer is a widespread disease affecting individuals globally. Challenges include timely diagnosis, accuracy, sensitivity, and reliable results from traditional methods. Delayed diagnosis often leads to metastasis of cancerous cells to axillary lymph nodes, complicating treatment and necessitating organ removal. The Laser-Induced Fluorescence Spectroscopy (LIFS) technique is notable for its high accuracy, sensitivity, and rapid capabilities in detecting various cancerous areas and cultured cell samples. Additionally, it is low-risk, cost-effective, and has minimal side effects. This research considers various cancer cell lines (MCF10 cells), highlighting their biological differences compared to human breast cells (MCF10 cells), referred to as the control. Due to the sensitivity of the proposed solution, this diagnostic tool can enhance breast cancer detection. The technique is ready for pre/post-clinical use as a non-invasive diagnostic tool, offering significant benefits in early diagnosis and patient evaluation before invasive procedures. Metabolic alterations in cancer cell lines result in differences in key fluorophores, such as NADH and Flavin, compared to normal cells. Variations in fluorescence emission provide a foundation for the characterization and diagnosis of breast cancer through fluorescence-guided approaches. Cancer cells show intense spectral peaks, while normal cells have a continuous fluorescence range.
چکیده انگلیسی :
Breast cancer is a widespread disease affecting individuals globally. Challenges include timely diagnosis, accuracy, sensitivity, and reliable results from traditional methods. Delayed diagnosis often leads to metastasis of cancerous cells to axillary lymph nodes, complicating treatment and necessitating organ removal. The Laser-Induced Fluorescence Spectroscopy (LIFS) technique is notable for its high accuracy, sensitivity, and rapid capabilities in detecting various cancerous areas and cultured cell samples. Additionally, it is low-risk, cost-effective, and has minimal side effects. This research considers various cancer cell lines (MCF10 cells), highlighting their biological differences compared to human breast cells (MCF10 cells), referred to as the control. Due to the sensitivity of the proposed solution, this diagnostic tool can enhance breast cancer detection. The technique is ready for pre/post-clinical use as a non-invasive diagnostic tool, offering significant benefits in early diagnosis and patient evaluation before invasive procedures. Metabolic alterations in cancer cell lines result in differences in key fluorophores, such as NADH and Flavin, compared to normal cells. Variations in fluorescence emission provide a foundation for the characterization and diagnosis of breast cancer through fluorescence-guided approaches. Cancer cells show intense spectral peaks, while normal cells have a continuous fluorescence range.
[1] Institute, N.C., cancer.gov, National Cancer Institute, http://www.cancer.gov/publications/ /patient/patient-education/understanding-brea- st-changes, 2024.
[2] M. Ghezelbash, B. Sajad, and S. Hojatizadeh, Fluorescence-Enhanced Assessments for Human Breast Cancer Cell Characterizations. Photonics, 2024. 11(8): p. 746.
[3] WHO, https://www.cancer.gov/about-cancer/ understanding/what-is-cancer. 2024.
[4] He, Z., et al., A review on methods for diagnosis of breast cancer cells and tissues. Cell Prolif, 2020. 53(7): p. e12822.
[5] Dramićanin, T. and M.D. Dramićanin. Using Fluorescence Spectroscopy to Diagnose Breast Cancer. 2016.
[6] Bernard Valeur, M.N.B.-S., Molecular Fluorescence: Principles and Applications, 2nd Edition. 2012: p. 592 Pages.
[7] Adhikari, S., et al., Effect of Invitro Zinc (II) supplementation on Normal and Cancer Cell lines. International Journal for Research in Applied Science & Engineering Technology (IJRASET), 2015. Volume 3 Issue I, ISSN: 2321-9653.
[8] Holliday, D.L. and V. Speirs, Choosing the right cell line for breast cancer research. Breast Cancer Research, 2011. 13(4): p. 215.
[9] Welsh, J., Chapter 40 - Animal Models for Studying Prevention and Treatment of Breast Cancer, in Animal Models for the Study of Human Disease, P.M. Conn, Editor. 2013, Academic Press: Boston. p. 997-1018.
[10] Lee, A.V., S. Oesterreich, and N.E. Davidson, MCF-7 cells--changing the course of breast cancer research and care for 45 years. J Natl Cancer Inst, 2015. 107(7).
[11] Segeritz, C.-P. and L. Vallier, Chapter 9 - Cell Culture: Growing Cells as Model Systems In Vitro, in Basic Science Methods for Clinical Researchers, M. Jalali, F.Y.L. Saldanha, and M. Jalali, Editors. 2017, Academic Press: Boston. p. 151-172.
[12] Croce, A.C. and G. Bottiroli, Autofluorescence spectroscopy and imaging: a tool for biomedical research and diagnosis. Eur J Histochem, 2014. 58(4): p. 2461.
[13] Tatjana, D. and M. Dramicanin, Using Fluorescence Spectroscopy to Diagnose Breast Cancer. 2016.
[14] Monici, M., Cell and tissue autofluorescence research and diagnostic applications, in Biotechnology Annual Review. 2005, Elsevier. p. 227-256.
[15] Martínez-Reyes, I. and N.S. Chandel, Cancer metabolism: looking forward. Nature Reviews Cancer, 2021. 21(10): p. 669-680.
[16] Yang, Y.L., et al., Characteristic autofluor- rescence for cancer diagnosis and its origin. Lasers Surg Med, 1987. 7(6): p. 528-32.
